Webinar Overview
\n\nMinimally invasive mitral valve repair for deg enerative mitral regurgitation has become increasingly popular. Several ob servational studies have suggested it is safe and effective\, with outcome s comparable to traditional open-heart surgery. For the first time\, a ran domized\, controlled trial has now compared the two approaches to surgical mitral valve repair.
\nPatients with degenerative mi tral regurgitation are best treated with surgical mitral valve repair\, bu t less invasive interventions such as transcatheter edge to edge repair ha ve caught the attention of both patients and cardiologists. The UK Mini Mi tral Trial randomized patients to either full sternotomy or mini-thoracoto my approach to mitral valve repair surgery\, assessing the benefits of a l ess invasive approach to mitral regurgitation. These results were presente d at the ACC.23 Scientific Sessions and implications of the trial will be discussed on this ACC webinar.
\nKey Objectives/Learn ing Outcomes: For the first time\, a randomized\, controlled trial has now compared the two approaches to surgical mitral valve repair.
\n\nWebinar Recording
\nWebina r Participants
\nS. Chris Malaisrie\, MD\, FACC Moderator\,
Chair ACC Cardiac Surgery Team Council
\nMoritz C. Wyler von Ballmoos\
, MD\, PhD\, MPH\, FACC\, Moderator\, ACC Cardiac Surgery Team Council Mem
ber
\nEnoch Francis Akowuah\, MD\, MRCS\, MBChB\, Speaker PI and 1st au
thor of UK Mini Mitral Trial
\nJoanna Chikwe\, MD\, FACC\, Panelist\, E
ditor in Chief\, Annals of Thoracic Surgery
\nWayne Batchelor\, MD\, MH
S\, FACC\, Chair ACC Interventional Council
No credit is being offered for this webinar.
\n\n